Persistent photopsia following course of oral voriconazole

Journal of Ocular Pharmacology and Therapeutics

Volumn 26, Issue 4, 2010, Pages 387-388

  Kadikoy, Huseyin ^a   Barkmeier, Andrew ^b   Peck, Brandon ^a   Carvounis, Petros E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b CULLEN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE; VORICONAZOLE;

ADULT; ARTICLE; CASE REPORT; COUGHING; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EYE COLOR; EYE DISEASE; FATIGUE; FEMALE; FOLLOW UP; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; LIGHT; MEDICAL RECORD REVIEW; MYELODYSPLASTIC SYNDROME; NIGHT SWEAT; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PHOTOPSIA; RETROSPECTIVE STUDY; SIDE EFFECT; TREATMENT DURATION; VISUAL ACUITY;

ADMINISTRATION, ORAL; ANTIFUNGAL AGENTS; FEMALE; HISTOPLASMOSIS; HUMANS; MIDDLE AGED; OCULAR PHYSIOLOGICAL PHENOMENA; PYRIMIDINES; TREATMENT OUTCOME; TRIAZOLES; VISION DISORDERS;

EID: 77955569746     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2010.0046     Document Type: Article

References (6)

1. Hariprasad, S.M., Mieler, W.F., Lin, T.K., Sponsel, W.E., and Graybill, J.R. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br. J. Ophthalmol. 92:871-878, 2008.
2. Hariprasad, S.M., Mieler, W.F., Holz, E.R., et al. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch. Ophthalmol. 122:42-47, 2004.
3. Shafaati, M., Mast, N., Beck, O., et al. The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase (CYP46A1) in vitro and in vivo. J. Lipid Res. 51:318-323, 2010.
4. Andes, D., Pascual, A., and Marchetti, O. Antifungal therapeutic drug monitoring: established and emerging indications. Antimicrob. Agents Chemother. 53:24-34, 2009.
5. Imhof, A., Schaer, D.J., Schanz, U., and Schwarz, U. Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring. Swiss Med. Wkly. 136:739-742, 2006.
6. Ingster-Moati, I., Bui Quoc, E., Crochet, M., Orssaud, C., Dufier, J.L., and Roche, O. Severe chloroquine-and hydro-xychloroquine-induced retinopathy. J. Fr. Ophtalmol. 29: 642-650, 2006.